204 related articles for article (PubMed ID: 19376375)
1. Hypertension induced by immunosuppressive drugs: a comparative analysis between sirolimus and cyclosporine.
Reis F; Parada B; Teixeira de Lemos E; Garrido P; Dias A; Piloto N; Baptista S; Sereno J; Eufrásio P; Costa E; Rocha-Pereira P; Santos-Silva A; Figueiredo A; Mota A; Teixeira F
Transplant Proc; 2009 Apr; 41(3):868-73. PubMed ID: 19376375
[TBL] [Abstract][Full Text] [Related]
2. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT;
Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194
[TBL] [Abstract][Full Text] [Related]
3. Dual effect of nitrate therapy for cyclosporine-induced hypertension on vascular and platelet morphofunctional markers; an animal model.
Reis F; Teixeira de Lemos E; Almeida L; Parada B; Garrido AP; Rocha-Pereira P; Santos-Silva A; Santos-Dias J; Dinis A; Figueiredo A; Costa-Almeida C; Mota A; Teixeira F
Transplant Proc; 2007 Oct; 39(8):2501-6. PubMed ID: 17954158
[TBL] [Abstract][Full Text] [Related]
4. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
5. Serum and renal tissue markers of nephropathy in rats under immunosuppressive therapy: cyclosporine versus sirolimus.
Sereno J; Parada B; Rodrigues-Santos P; Lopes PC; Carvalho E; Vala H; Teixeira-Lemos E; Alves R; Figueiredo A; Mota A; Teixeira F; Reis F
Transplant Proc; 2013 Apr; 45(3):1149-56. PubMed ID: 23622648
[TBL] [Abstract][Full Text] [Related]
6. Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine.
Romagnoli J; Citterio F; Nanni G; Favi E; Tondolo V; Spagnoletti G; Salerno MP; Castagneto M
Transplant Proc; 2006 May; 38(4):1034-6. PubMed ID: 16757255
[TBL] [Abstract][Full Text] [Related]
7. Effect of different immunosuppressive therapies on the lipid pattern in kidney-transplanted rats.
Lausada N; de Gómez Dumm Nelva T; Georgina L; Gisela C; Clemente R
Transpl Int; 2005 May; 18(5):524-31. PubMed ID: 15819800
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressant use without bone loss--implications for bone loss after transplantation.
Goodman GR; Dissanayake IR; Sodam BR; Gorodetsky E; Lu J; Ma YF; Jee WS; Epstein S
J Bone Miner Res; 2001 Jan; 16(1):72-8. PubMed ID: 11149492
[TBL] [Abstract][Full Text] [Related]
9. The combination of sirolimus and cyclosporine does not delay initial renal graft function recovery.
Hsu HJ; Tian YC; Chen YC; Lai BC; Fang JT; Yang CW; Wu MS
Ren Fail; 2008; 30(3):303-6. PubMed ID: 18350450
[TBL] [Abstract][Full Text] [Related]
10. Dyslipidemia during sirolimus therapy in patients after liver transplantation.
Kniepeiss D; Iberer F; Schaffellner S; Jakoby E; Duller D; Tscheliessnigg Kh
Clin Transplant; 2004 Dec; 18(6):642-6. PubMed ID: 15516237
[TBL] [Abstract][Full Text] [Related]
11. Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene.
Han DH; Piao SG; Song JH; Ghee JY; Hwang HS; Choi BS; Kim J; Yang CW
Transplantation; 2010 Jul; 90(2):135-41. PubMed ID: 20562737
[TBL] [Abstract][Full Text] [Related]
12. Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma.
Yi T; Cuchara L; Wang Y; Koh KP; Ranjbaran H; Tellides G; Pober JS; Lorber MI
Transplantation; 2006 Feb; 81(4):559-66. PubMed ID: 16495804
[TBL] [Abstract][Full Text] [Related]
13. Decreased cardiovascular responses to cisterna magna NaCl injection in hypertensive rats.
Romero-Vecchione E; Vásquez JV; Dávoli MA; Quijada G; Rosa F
Acta Cient Venez; 1996; 47(1):11-6. PubMed ID: 9334446
[TBL] [Abstract][Full Text] [Related]
14. Prospective comparison of the use of sirolimus and cyclosporine in recipients of a kidney from an expanded criteria donor.
Durrbach A; Rostaing L; Tricot L; Ouali N; Wolf P; Pouteil-Noble C; Kessler M; Viron B; Thervet E
Transplantation; 2008 Feb; 85(3):486-90. PubMed ID: 18301342
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclosporine and sirolimus on insulin-stimulated glucose transport and glucose tolerance in a rat model.
Lopes P; Fuhrmann A; Sereno J; Pereira MJ; Nunes P; Pedro J; Melão A; Reis F; Carvalho E
Transplant Proc; 2013 Apr; 45(3):1142-8. PubMed ID: 23622647
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat.
Wittmann S; Daniel C; Stief A; Vogelbacher R; Amann K; Hugo C
Transplantation; 2009 May; 87(9):1290-9. PubMed ID: 19424027
[TBL] [Abstract][Full Text] [Related]
17. Is sirolimus responsible for proteinuria?
Dervaux T; Caillard S; Meyer C; Ellero B; Woehl-Jaegle ML; Hannedouche T; Wolf P; Moulin B
Transplant Proc; 2005; 37(6):2828-9. PubMed ID: 16182822
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens.
Gyurus E; Kaposztas Z; Kahan BD
Transplant Proc; 2011 Jun; 43(5):1583-92. PubMed ID: 21693238
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in white coat hypertension; role of paraoxonase.
Uzun H; Karter Y; Aydin S; Curgunlu A; Simşek G; Yücel R; Vehiyd S; Ertürk N; Kutlu A; Benian A; Yaldiran A; Oztürk E; Erdine S
J Hum Hypertens; 2004 Jul; 18(7):523-8. PubMed ID: 14985779
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine A-induced nephrotoxicity is ameliorated by dose reduction and conversion to sirolimus in the rat.
Sereno J; Vala H; Nunes S; Rocha-Pereira P; Carvalho E; Alves R; Teixeira F; Reis F
J Physiol Pharmacol; 2015 Apr; 66(2):285-99. PubMed ID: 25903959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
